GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guardion Health Sciences Inc (STU:0QTA) » Definitions » Change In Payables And Accrued Expense

Guardion Health Sciences (STU:0QTA) Change In Payables And Accrued Expense : €-0.61 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Guardion Health Sciences Change In Payables And Accrued Expense?

Guardion Health Sciences's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was €-0.00 Mil. It means Guardion Health Sciences's Accounts Payable & Accrued Expense declined by €0.00 Mil from Sep. 2023 to Dec. 2023 .

Guardion Health Sciences's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was €-0.59 Mil. It means Guardion Health Sciences's Accounts Payable & Accrued Expense declined by €0.59 Mil from Dec. 2022 to Dec. 2023 .


Guardion Health Sciences Change In Payables And Accrued Expense Historical Data

The historical data trend for Guardion Health Sciences's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guardion Health Sciences Change In Payables And Accrued Expense Chart

Guardion Health Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only 0.02 0.53 -0.06 0.89 -0.59

Guardion Health Sciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 -0.63 0.04 -0.01 -

Guardion Health Sciences Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guardion Health Sciences Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Guardion Health Sciences's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Guardion Health Sciences (STU:0QTA) Business Description

Traded in Other Exchanges
Address
2925 Richmond Avenue, Suite 1200, Houston, TX, USA, 77098
Guardion Health Sciences Inc is a specialty health sciences company formed to develop, formulate and distribute condition-specific medical foods with an initial medical food product. The company's Medical Foods include Lumega-Z and GlaucoCetin; Medical Devices include Mapcat SF, VectorVision, CSV-1000 and CSV-2000; Nutraceuticals include ImmuneSF.

Guardion Health Sciences (STU:0QTA) Headlines

No Headlines